Dyslipidemia Associated With Type II Diabetes Mellitus Clinical Trial
Official title:
National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.
The purpose of this study is to evaluate the efficacy and safety of Berlim 25/20 association in the treatment of type 2 diabetes mellitus and dyslipidemia.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05563090 -
Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
|
||
Completed |
NCT05072990 -
Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine
|
||
Completed |
NCT03932721 -
EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial
|
Phase 4 | |
Terminated |
NCT03258281 -
Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus
|
Phase 4 | |
Not yet recruiting |
NCT05128747 -
Effectiveness of Nutritional Program Among Diabetic Patients
|
N/A | |
Completed |
NCT05806723 -
Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
|
Phase 4 | |
Recruiting |
NCT04943926 -
Dietary Strategies for Remission of Type 2 Diabetes
|
N/A | |
Completed |
NCT05107063 -
An Observational Study Investigating the Effectiveness of Pravastatin on Renal Function in Korean Dyslipidemic Patients With Type 2 Diabetes
|
||
Completed |
NCT03784703 -
Type 2 Diabetic Patients Maintained on Statin Therapy
|
Phase 4 | |
Recruiting |
NCT04882293 -
Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.
|
Phase 3 |